WRN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.410200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.802600E-01
Normal-vs-Stage2
7.606200E-01
Normal-vs-Stage3
1.397970E-01
Normal-vs-Stage4
2.669200E-01
Stage1-vs-Stage2
6.414400E-01
Stage1-vs-Stage3
2.364200E-01
Stage1-vs-Stage4
3.589800E-01
Stage2-vs-Stage3
2.190000E-01
Stage2-vs-Stage4
9.748200E-02
Stage3-vs-Stage4
2.901900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.206200E-01
Normal-vs-AfricanAmerican
6.667600E-01
Normal-vs-Asian
3.978800E-01
Caucasian-vs-AfricanAmerican
2.198600E-01
Caucasian-vs-Asian
3.101400E-01
AfricanAmerican-vs-Asian
1.289820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.444600E-01
Normal-vs-Female
9.653400E-01
Male-vs-Female
4.905600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.955000E-01
Normal-vs-Age(41-60Yrs)
9.471200E-01
Normal-vs-Age(61-80Yrs)
6.890600E-01
Normal-vs-Age(81-100Yrs)
4.886200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.945200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.741000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.366200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.505800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.358200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.144000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.396800E-01
Normal-vs-Daily Drinker
2.513600E-01
Normal-vs-Weekly Drinker
8.850200E-01
Normal-vs-Occasional Drinker
6.872000E-01
Normal-vs-Social Drinker
6.722000E-01
Non Drinker-vs-Daily Drinker
4.977800E-01
Non Drinker-vs-Weekly Drinker
6.792100E-02
Non Drinker-vs-Occasional Drinker
4.124200E-01
Non Drinker-vs-Social Drinker
4.645700E-02
Daily Drinker-vs-Weekly Drinker
3.987700E-02
Daily Drinker-vs-Occasional Drinker
2.093600E-01
Daily Drinker-vs-Social Drinker
1.222190E-02
Weekly Drinker-vs-Occasional Drinker
3.691400E-01
Weekly Drinker-vs-Social Drinker
5.985600E-01
Occasional Drinker-vs-Social Drinker
1.578170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.912850E-01
Normal-vs-Grade 2
8.270300E-02
Normal-vs-Grade 3
5.135600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.181600E-01
Grade 1-vs-Grade 3
5.086000E-02
Grade 1-vs-Grade 4
1.912850E-01
Grade 2-vs-Grade 3
2.497400E-01
Grade 2-vs-Grade 4
8.270300E-02
Grade 3-vs-Grade 4
5.135600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.683400E-01
Normal-vs-NonDiabetic
6.134200E-01
Diabetic-vs-NonDiabetic
6.418600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.681400E-01
Normal-vs-NoPancreatitis
6.132400E-01
Pancreatitis-vs-NoPancreatitis
7.205800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.541000E-01
Normal-vs-N1
7.639400E-01
N0-vs-N1
8.332000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.955600E-01
Normal-vs-TP53-NonMutant
9.507000E-01
TP53-Mutant-vs-TP53-NonMutant
8.318200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
